DECEMBER 2026  SEEDWORLD.COM /  29
The Only Return that Really Counts
As an industry, we also need to be more disciplined about how 
we discuss performance. It's easy to talk about a five-, six- or 
eight-bushel yield response. Those numbers need to be backed by 
extensive evidence, of course. Even then, they mean relatively little 
without knowing what the grower paid to achieve them.
Take PathoShield in U.S. corn. At our current pricing, a grower 
needs approximately one additional bushel per acre to cover the 
product cost. Historically, we've seen four- to five-bushel respons­
es in greater than 75% of our trials, with a typical return of roughly 
five dollars for every dollar invested. 
We have more than 7,500 field trials across our portfolio, 
including our own research, university collaborations and com­
mercial grower demonstrations. Our technologies have been used 
on more than 15 million acres globally. Even with that experi­
ence, I wouldn't suggest that each of our solutions works equally 
well everywhere. We continue to focus on understanding which 
environments, crops and production conditions favour particular 
microorganisms, and be transparent about where growers should 
expect the greatest benefit.
Biologicals should complement conventional crop protection 
programs, providing additional modes of action and opportunities 
to protect yield. They don't need to replace every existing tool to 
justify their place in the program.
Finding the Next Generation of Biologicals
ENAI (from Endophytes and Artificial Intelligence) became in­
dependent from Indigo Agriculture in August 2026. While we’re a 
new entity, the scientific and commercial foundation behind us 
has been built over more than a decade.
Indigo operated across biologicals, sustainability and carbon 
markets. Separating those businesses allows us to concentrate our 
resources on microbial innovation, particularly endophytic crop 
protection, while maintaining the Indigo heritage of innovation.
We have approximately 36,000 microbial strains in our propri­
etary library and more than 32 million data points. Our challenge 
now is extracting more value from all that information.
Through Flagship's broader innovation ecosystem, we're utiliz­
ing AI and machine-learning with our proprietary intelligence 
to screen microbial strains against specific disease, insect and 
nematode targets, accelerating the identification of promising 
candidates. 
Consistency has been one of the biggest challenges with bio­
logicals, and an area AI can make a real difference. The better we 
understand the conditions under which a particular microorgan­
ism performs, the more precisely we can match products to crops, 
environments and grower needs. That gives seed companies and 
retailers more confidence in what they're recommending, and 
growers a better chance of seeing the return they expect.
I'm especially interested in what this means for new biofungi­
cides, bioinsecticides and bionematicides. Resistance continues to 
put pressure on existing crop protection chemistry, while rela­
tively few genuinely new modes of action are reaching the mar­
ket. Growers need additional tools, and the seed industry has an 
important role in delivering them.
Where Seed Companies Fit 
ENAI’s independence also creates opportunities for collabora­
tion. We have a branded commercial portfolio, but we also work 
through private label distribution, retail, agricultural chemical 
and seed industry partners. We're interested in collaborating 
wherever our technology can strengthen an existing offering or 
help bring a new solution to market. 
Seed companies are particularly interesting partners because 
seed is such a practical delivery system for endophytic microor­
ganisms. There's potential to explore how biologicals fit within 
a differentiated seed offering, how particular microorganisms 
perform across crops and environments, and how we can develop 
more targeted solutions together.
We're already active commercially in North America, South 
America and Europe, and we're exploring opportunities beyond 
corn and soybeans, including potatoes, strawberries, lettuce and 
other high-value crops. What excites me most is connecting the 
discovery work happening in our laboratories with the commer­
cial experience and market access of our partners.
Over the next five to 10 years, resistance and regulatory pres­
sures will continue to challenge conventional crop protection 
programs. I want biologicals to earn a permanent place in that 
conversation. After 25 years in this industry, I've become pretty 
demanding about what earns a place in a grower's program. The 
science has to hold up, the economics have to make sense, and the 
product has to work within the realities of commercial agriculture. 
I've seen what endophytes can deliver on all three fronts, and I'm 
excited about how much further we can take this technology.
Above: Nemora biological 
nematicide bacteria (glowing 
points) swarm soybean cyst 
nematode eggs (dark ovals).
Left: M46 microbial 
biostimulant improves water 
and nutrient use efficiency 
through Coniochaeta nivea, a 
fungus whose hyphae (green) 
act as additional corn root hairs 
(root cells in red).

View this content as a flipbook by clicking here.